10 January 2022
Rymarz Zdort advised HigoSense sp. z o.o. (“HigoSense”), a Warsaw-based digital healthcare provider, and its founders in connection with a EUR 5 million Series A funding round led by Cogito Capital Partners, with the participation of existing early-stage investors.
HigoSense, is a health-tech start-up established in 2017 offering a mobile medical examination device that is supported by a mobile app and an online AI-powered health diagnostic platform. HigoSense enables doctors to perform high-quality remote patient examinations and patients to perform examinations, as well as collect diagnostic data prior to or during a telehealth session.
Cogito Capital Partners focuses on providing support in management, financing and market expansion to technology companies with high-growth potential and helping them expand internationally.
The team advising on the transaction comprised Paweł Zdort, a managing partner, supported by Monika Michałowska, an associate. Robert Krasnodębski, a partner, was responsible for the tax aspects of the transaction.
16 April 2024
We are pleased to announce that we advised Huuuge, Inc. (“Huuuge”) on the execution of a simple agreement for future equity and a call option deed agreement with an Israeli mobile game company and its...
15 April 2024
We are pleased to announce that Rymarz Zdort Maruta advised Mycofeast LTD on the acquisition of the Leżajsk Brewery from Grupa Żywiec sp. z o.o. The preliminary conditional investment and share p...
12 April 2024
We are pleased to announce that we advised Węglokoks on the acquisition of 80% of the shares in Przedsiębiorstwo Przeładunkowo-Składowe “Port Północny” from the Belgian group Sea-Invest. However, Węgl...
